Brind.

BridgeBio reported strong sales performance and benefits from Trump-era tariffs and onshoring trends, according to TD Cowen.

1 report, 1 independent Updated Aug 20

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

BridgeBio Donald Trump

Keep exploring

The entities involved

BridgeBio
company in Palo Alto, United States

Nothing else this week.
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- Donald Trump has commented on an issue while Laurie Jinkins serves as a state House Speaker in Washington.18:07
- Netanyahu complicated peace negotiations with Tehran amid recent US-Iran attacks and a meeting cancellation by Pete Hegseth.18:07

Related events

Trump tariffs are reshaping commercial patterns across various industries.Sat 15:13

Coverage

Newest first; wire copies grouped

Aug 20Insider MonkeyTD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO) on Strong Attruby Sales BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the best Russell 2000 stocks to buy now. On August 6, TD Cowen reitera